Deep Track Capital, LP
Top Portfolio Positions
62 positions ·
$4,902,963,139 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| GH |
Guardant Health, Inc.
Healthcare
|
3,338,241 | $308,353,321 | 6.29% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
11,526,971 | $286,329,959 | 5.84% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
3,600,000 | $252,540,000 | 5.15% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
4,300,000 | $249,873,000 | 5.10% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
4,279,848 | $206,288,673 | 4.21% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
1,100,000 | $185,922,000 | 3.79% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
4,532,374 | $182,337,406 | 3.72% | |
| OCUL |
Ocular Therapeutix, Inc
Healthcare
|
19,686,282 | $166,742,808 | 3.40% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
4,106,067 | $165,187,075 | 3.37% | |
| ALMS |
Alumis Inc.
Healthcare
|
6,772,595 | $149,200,267 | 3.04% |
Portfolio Trend
18 quarters · across all stocks
Holdings in MBX
Shares Held
Position Value (USD)
7 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $82,313,434 | 2,757,569 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $102,498,376 | 3,249,790 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $55,125,000 | 3,150,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $24,971,834 | 2,188,592 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,279,740 | 3,018,935 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $55,638,972 | 3,018,935 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $78,431,931 | 3,018,935 | Shares | Sole | 2024-11-14 | |
| No 13F history on record for this holder in this stock. | ||||||